Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 272 papers

Acute-on-chronic liver failure: Current interventional treatment options and future challenges

Kimmann M, Trebicka J.

J Pers Med 2023, 13(7):1052

DOI: 10.3390/jpm13071052

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

European Association for the Study of the Liver

J Hepatol 2023, 79(2): 461–491

DOI: 10.1016/j.jhep.2023.04.021

Acute-on-chronic liver failure: Definition, diagnosis, and clinical characteristics

Arroyo V, Jalan R.

Semin Liver Dis 2016, 36(2): 109–116

DOI: 10.1055/s-0036-1583202

Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis

Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, Laleman W, Trebicka J, Elkrief L, Hopf C, Solís-Munoz P, Saliba F, Zeuzem S, Albillos A, Benten D, Montero-Alvarez JL, Chivas MT, Concepción M, Córdoba J, McCormick A, Stauber R, Vogel W, de Gottardi A, Welzel TM, Domenicali M, Risso A, Wendon J, Deulofeu C, Angeli P, Durand F, Pavesi M, Gerbes A, Jalan R, Moreau R, Ginés P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium.

Hepatology 2015, 62(1): 243–52

DOI: 10.1002/hep.27849

Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure

Ballester MP, Elshabrawi A, Jalan R.

Liver Int 2023

DOI: 10.1111/liv.15647

Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure

Clària J, Arroyo V, Moreau R.

JHEP Rep 2023, 5(9):100807

DOI: 10.1016/j.jhepr.2023.100807

Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure

Schierwagen R, Gu W, Brieger A, Brüne B, Ciesek S, Đikić I, Dimmeler S, Geisslinger G, Greten FR, Herrmann E, Hildt E, Kempf VAJ, Klein S, Koch I, Mühl H, Müller V, Peiffer KH, Kestner RI, Piiper A, Rohde G, Scholich K, Schulz MH, Storf H, Toptan T, Vasa-Nicotera M, Vehreschild MJGT, Weigert A, Wild PJ, Zeuzem S, Engelmann C; ACLF-I investigators; Schaefer L, Welsch C, Trebicka J.

Am J Physiol Cell Physiol 2023

DOI: 10.1152/ajpcell.00101.2023

Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis

Ballester MP, Tranah TH, Balcar L, Fiorillo A, Ampuero J, Kerbert AJC, Thomsen KL, Escudero MD, Mandorfer M, Reiberger T, Shawcross DL, Romero-Gómez M, Montoliu C, Carbonell-Asins JA, Jalan R.

J Hepatol 2023, S0168-8278(23)00351-3

DOI: 10.1016/j.jhep.2023.05.022

Sphingolipids are depleted in alcohol-related liver fibrosis

Thiele M, Suvitaival T, Trošt K, Kim M, de Zawadzki A, Kjaergaard M, Rasmussen DN, Lindvig KP, Israelsen M, Detlefsen S, Andersen P, Juel HB, Nielsen T, Georgiou S, Filippa V, Kuhn M, Nishijima S, Moitinho-Silva L, Rossing P, Trebicka J, Anastasiadou E, Bork P, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium; GALAXY Consortium.

Gastroenterology 2023, 164(7): 1248–1260

DOI: 10.1053/j.gastro.2023.02.023

Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

Agarwal B, Cañizares RB, Saliba F, Ballester MP, Tomescu DR, Martin D, Stadlbauer V, Wright G, Sheikh M, Morgan C, Alzola C, Lavin P, Green D, Kumar R, Sacleux SC, Schilcher G, Koball S, Tudor A, Minten J, Domenech G, Aragones JJ, Oettl K, Paar M, Waterstradt K, Bode-Boger SM, Ibáñez-Samaniego L, Gander A, Stange J, Lamprecht G, Sanchez M, Mookerjee RP, Davenport A, Davies N, Pavesi M, Andreola F, Albillos A, Cordingley J, Schmidt H, Carbonell-Asins JA, Arroyo V, Fernandez J, Mitzner S, Jalan R.

J Hepatol 2023, 79(1): 79–92

DOI: 10.1016/j.jhep.2023.03.013